Abiopharma

Asana to Present at Upcoming Investor Events

Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy

Empire State Realty Trust to Present at The Nareit REITweek 2026 Investor Conference

Fathom Holdings Inc. Receives Notification from Nasdaq Regarding Late Filing of Form 10-Q

Target Hospitality Announces Closing of Secondary Offering and Full Exercise of Underwriters Option to Purchase Additional Shares

Rocky Mountain Chocolate Factory Schedules Fiscal Fourth Quarter and Full Year 2026 Conference Call for June 2, 2026 at 9:00 A.M. ET

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Arvinas to Present at Jefferies Global Healthcare Conference

Tiptree and Warburg Pincus Announce Closing of Fortegra Sale

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)